Genetic basis of anthracyclines cardiotoxicity: Literature review
The purpose of this review was to systematize data on molecular genetic markers of increased risk of cardiotoxic effects, as well as to search for risk and protective variants of candidate genes. Today, the therapy of malignant neoplasms is based on the use of anthracyclines – drugs of the cytostati...
Guardado en:
Autores principales: | M. Yu. Sinitsky, A. V. Tsepokina, M. V. Khutornaya, A. V. Ponasenko, A. N. Sumin |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Scientific Сentre for Family Health and Human Reproduction Problems
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3824f05d5c5d4a4193d6bca3f450f543 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potential role of epicardial adipose tissue as a biomarker of anthracycline cardiotoxicity
por: Caterina Beatrice Monti, et al.
Publicado: (2021) -
Impacto cardiovascular secundario a la terapia para el control del cáncer
por: Ríos,Juvenal A., et al.
Publicado: (2020) -
Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
por: Sousa,MG, et al.
Publicado: (2014) -
Weighted gene co-expression network-based approach to identify key genes associated with anthracycline-induced cardiotoxicity and construction of miRNA-transcription factor-gene regulatory network
por: Guoxing Wan, et al.
Publicado: (2021) -
<i>POLRMT</i> as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients
por: Alejandro Velasco-Ruiz, et al.
Publicado: (2021)